Recent Updates
Recently added Catalysts
AORT Neutral Sentiment Score: 60/100

Artivion Announces Release Date and Teleconference Call Details for Second Quarter 2025 Financial Results Artivion, Inc. (NYSE: AORT), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2025...

Key Takeaway: Artivion, Inc. announced that it will release its second quarter 2025 financial results on August 7, 2025, after the market closes. A teleconference call is scheduled for the same day at 4:30 p.m. ET, where company executives will discuss the results and answer questions. Artivion focuses on providing innovative medical solutions for cardiac and vascular surgery, specifically targeting aortic disease.

Market Sentiment Analysis

POSITIVE FACTORS

  • Artivion is scheduled to release its financial results soon.
  • The company emphasizes its focus on innovative solutions for aortic disease.
  • Management will engage with investors through a teleconference.

Full Press Release Details

ATLANTA , July 24, 2025 /PRNewswire/ -- Artivion, Inc. (NYSE: AORT ), a leading cardiac and vascular surgery company focused on aortic disease, announced today that second quarter 2025 financial results will be released on Thursday, August 7, 2025 , after the market closes. On that day, the Company will hold a teleconference call and live webcast at 4:30 p.m. ET to discuss the results, followed by a question-and-answer session hosted by Pat Mackin , Chairman, President and Chief Executive Officer of Artivion.
To listen to the live teleconference, please dial 862-298-0702 a few minutes prior to 4:30 p.m. ET . The teleconference replay will be available approximately one hour following the completion of the event and can be accessed by calling (toll free) 877-660-6853 or 201-612-7415. The conference number for the replay is 13754541.
The live webcast and replay can be accessed on the Investors section of the Artivion website at www.artivion.com and by selecting Webcasts & Presentations. In addition, a copy of the earnings press release, which will contain financial and statistical information for the completed quarter and full year, can be accessed in the Investors section of the Artivion website.
About Artivion, Inc. Headquartered in suburban Atlanta, Georgia , Artivion, Inc. is a medical device company focused on developing simple, elegant solutions that address cardiac and vascular surgeons' most difficult challenges in treating patients with aortic diseases. Artivion's four major groups of products include: aortic stent grafts, surgical sealants, On-X mechanical heart valves, and implantable cardiac and vascular human tissues. Artivion markets and sells products in more than 100 countries worldwide. For additional information about Artivion, visit our website, www.artivion.com .
SOURCE Artivion, Inc.

21 %

Frequently Asked Questions

When will Artivion release its Q2 2025 financial results?

Artivion will release its Q2 2025 financial results on August 7, 2025.

How can I join the Artivion financial results teleconference?

You can join the teleconference by dialing 862-298-0702 before 4:30 p.m. ET.

Where can I access the replay of the teleconference?

The replay can be accessed by calling 877-660-6853 or 201-612-7415.

What types of products does Artivion develop?

Artivion develops aortic stent grafts, surgical sealants, heart valves, and human tissues.

How can I access the webcast of Artivion's results?

The webcast can be accessed on Artivion's website in the Investors section.

Last updated: Jul 24, 2025